Sunday, April 20, 2014

The $0.60 Penny Stock Rule

The $0.60 Penny Stock Rule

I see a lot of patterns in the market to identify trades.  Some of these patterns I NEVER hear anyone talking about.

The one rule that I see appearing over and over again that no one talks about is the $0.60 penny stock rule.   It is very simple.   $0.60 to $0.70 for any stock is a MASSIVE WALL of resistance.  I don’t know why.  I don’t make the rules.  I just point them out.   So how does this rule work? 

This is how I think it works.  Psychologically an investor will go way out on the risk curve for leverage. Why?  Simply because most will buy based on the fact that small movements produce big gains and at $0.60 the leverage that a ‘penny stock’ offers is lost.  So why is this important?  Simple.  For a penny stock to move up and approach $1… psychologically the investment must be seen as more legitimate by the investor and a ‘sure bet’ vs. a riskier stock bought sub $0.30.   This psychological tug of war between risk and reward plays out huge in this area.

So how do you trade it or know when confirmation happens? 

Well nothing is certain in life... but generally $0.60 to $0.70 acts as any normal support resistance band.   $0.60 is an ultimate wall for many stocks to get past and if it does generally you like to see price action move quickly to $0.70.   Those stocks usually have very strong momentum and the breakout can happen all within a few hours.  When ARU first announced results the company pushed past this mark easily and you knew to jump in.  (Well at the time I didn’t know, but after watching stock after stock perform the same way) you get a good idea.  ARU was the first ticker to really jump on my screen like that but not the last.   NOT-V did a textbook run as well and broke through another key penny land support resistance channel at $0.30 to $0.40.  HAT-V did the SAME thing when they announced acquiring Roughrider initially and ran all the way to $1.50 within weeks.  As you probably know the history with all three stocks if you at all have followed my blogs over the years… ALL WENT ON EPIC multi-dollar runs.

Usually the companies will make their way to $1 at least for a trade.  Sometimes the company doesn’t have that firepower and huge volume days and the signal isn’t as easy.   What tends to happen is it hits a second resistance at $0.70 and tries to forma base at $0.60 using it as support.  If the SP cannot hold $0.60 support, the SP will fall back significantly for a better entry point.  In both cases the stocks are moving and following a trendline which you can use in conjunction with horizontal support to pick the best entry points.   Examples of this are OPL-V back in December failing to maintain $0.60 and now KLH-V failing to maintain $0.60.  OPL-V is trying to maintain $0.60 and this mark may or may not hold… but even if it doesn’t… the base it’s built under $0.60 is looking like a good entry point.   The time of year is not the best so you have to be cautious opening up any bullish trades in March.



Another point to remember is I only use these bands as a BUY signal for momentum.  They do act as support for beaten up stocks like WRN and LIM but are not as accurate at predicting continuation in price action.    You do not want to own any stock that breaks support at $1 as they move well below that mark.



One final point…  This $0.60 cent mark can be used as a sell signal too.  If you own a penny stock from $0.20 or $0.30…  a stock that does not even break $0.60 moving up that significantly or trade a couple of days above… WILL MATERIALLY FALL BACK OFF $0.60. 

Is this type of price action time and time again.

From now on… just call me 60 cent.     

Friday, April 4, 2014

5 Canadian Cannabis Companies

Is the party in Cannabis stocks over?


A couple investors seem to think the run in cannabis stocks is over.    I am here to tell you the Cannabis run is just getting started.  If the run was done… would TWEED be IPO’ing in Canada?

NO.

Certainly the cannabis group of stocks is the most volatile I have ever seen in my 9 short years on the stock scene.  This has been magnified in Canada with companies like Abattis and Enertopia literally bouncing up and down like a yo-yo moving double digit percentages every day because of the legal battle between MMAR and the government.   No one knows what to do, and the emotional tug of war is being played out right in the SPs of the companies.  Great for a trader, not so much an investor trying to get a toe hold in this sector.

By no means is the cannabis party over. 

The massive surges in the SPs of many stocks and subsequent daily swings in SP is a great metaphor for the battle for legalization.  It is happening, the stocks are surging, but the pessimism and worry are still there because of 40 years of Drug War propaganda and the simple fact it is still illegal.  The stocks are still on an upward track.  Clearly if they were going to crash back down US companies like CBIS and ENDO would be back down at $0.02 a share.   ENDO is trading 50% below its share price of last April.

The fact the USA still has not reclassified cannabis is holding this industry back.  The biggest thing that can happen for cannabis is for the USA to reclassify the drug so business can take the ball and run with it.  This is far and away the single factor holding research cannabis back, not allowing companies to research cannabis.  Even getting drugs from GWPH approved because it is still considered cannabis is a nightmare process in the USA.

Nevertheless, the cannabis movement marches forward in spite of the ‘Establishment’s’ unwillingness to let the cannabis issue go.    Even the Establishment is breaking apart on this issue.  George Soros, Bill Gates and now Jimmy Pattison all quietly pushing this industry forward and on the corporate side of now have giants like Phillip Morris incubating this industry.

You can pretty much declare the war one, it is only a matter of time and the smart money knows this.

So to answer the pessimist’s question.  No, it ain’t over… the cannabis party is just getting started.


Recreation vs. Medical Marijuana

Companies do not have to differentiate yet, but the industry is developing at lightning speed and companies need to have a grasp on where this industry is going.  One of the biggest things I can’t stress enough is that the recreational and medical markets will separate at some point.  Right now the two are one and the same and most companies do not need to differentiate at the moment, but as this industry develops most companies will need to pick a field to focus on.
Both markets are extremely lucrative and there are obvious synergies but, the two businesses will require two completely different business plans and most companies will not have the resources to follow successfully execute in both markets.   In addition, what a medical user needs may not be what a recreational user want and vice versa.  A medical user will can consume ten times as much as rec user requiring different pricing models.   

Recreational markets will rely heavily on traditional business practices such as product branding, corporate acquisition, deciding the right mix of low cost mass production vs. product niches and developing products based on consumer enjoyment.  In the recreational market you will eventually buy pre-rolled low THC cigarettes for the same price as a pack of smokes and you will have concentrates as high as 99% THC and everything in between.

A large part of the industry will follow a model similar to a craft brewery model while other companies will go after the lowcost pre-rolled cigarette market.   I am sure that is Benson and Hedges plan… to eventually replace a majority of their tobacco fields with cannabis fields.  Raw weed will eventually be dirt cheap and sold like cigarettes.   If you grow it outdoors, it is even cheaper to produce than tobacco because of the enormous yields cannabis can produce outdoors.   Many people will prefer a slight coffee like buzz a 5% to 10% cannabis cigarette will produce than getting fully stoned on a 20% THC joint.   

Medical cannabis companies will be developing products based on physical need and will have a specific array and dose of cannabinoids tailored to a specific condition.   The medical market will be focusing on developing medicines from raw weed that are 10 to 100 times more effective than raw weed.  Cannabis Oil is the first of many products that medical marijuana companies will produce.  These products are not intended to get you high and PLPL is developing technology to turn the high off.

 What I predict from my own experience as a medical user…
within 5 years raw weed will be relegated to the recreational market.

At this point in time, marijuana companies do not have to differentiate between the medical and recreational markets, but faster than you can read this newsletter the industry is already changing.



Abattis Bioceuticals Corp.  $1.86



ATT:CNX; ATTBF:OTC

Shares Outstanding… 47.6M
Market Cap… $88.5M 



Abattis remains a top pick out on the West Coast in the Medical Marijuana scene.   I have ATT/ATTBF firmly entrenched in the MMJ sector and expect Abattis to follow a track similar to PLPL.  Yes I have said PLPL is a top recreation pick, but PLPL is one of the few companies that I think will transcend both recreation and medical cannabis.   Abattis has methodically developed a plan of attack and is now executing on that plan.

  • Received their controlled substances licence which allows them to develop extracts, concentrates and oils from the cannabis they grow.  
  • Expanded into the US markets developing strategic alliances with companies like Transbyte ERBB
  • Owns arguably the top one of the top vegetable concentration technologies which can be readily applied to cannabis. 
  • Own Vertical Designs, a patented vertical growing technology they plan on licencing to other growers.   Vertical Designs growing technology maximizes space and light efficiencies allowing for the greatest yields of indoor hydroponics systems.
Abattis has emerged as the market leader out west and is entrenching themselves as one of the top medical cannabis companies in North America, let alone Canada.



Tweed Marijuana Inc. $2.55

TWD:TSXV

Shares Out… 33.5M
Market Cap… $88.8M



Tweed IPO’d today at $0.89.  I say $0.89 because that is what the price the insiders paid.  Nobody buying on market will ever see those prices.  GMP opened Tweed at $4.60 which has been promptly sold down to $2.50 which seems like a decent entry point for this much anticipated stock.   Typical of finance guys… they open the stock high and clean out all the retail who bought in the morning, this tactic really irks me.  Yeah, it’s playing the game… but they are playing against players that have no idea it’s a game or that they are even playing and are losing 50% of the shirt in 15 minutes. 

But what do you expect… finance guys love picking the pockets of the guys they are supposed to be serving.   It happens time and time again and with a reputation like GMP… are you surprised?

At any rate, I have Tweed pegged as recreation stock.  They are basically born out of a network of compassion clubs back east and they spent most of their money buying MMAR strains from different patients in Ontario which I can accept as a good practice.  Tweed has 80 strains of cannabis so yes they are a medical marijuana company, but clearly their focus is going to be selling dope to the masses.  They have a retail production/distribution strategy that matches compassion clubs with no clear plan on developing MMJ products or putting millions into R & D to bring the industry forward.   So I have them clearly pegged as a recreational player.   GMP is going up against the likes of Phillip Morris… it’s a good thing they are early movers in Canada.  They are going to need the head start.

I expect, Tweed to fully grow into its valuation.   I believe Tweed will sell a lot of pot at very high prices to start padding the bottom line, but this industry will get very cutthroat within 5 years so I wonder how they will react to all out legalization with Trudeau.  Expect a lot from the income statement and balance sheet of this company being Canada’s largest marijuana dealer.

At least expect a lot out of the top line from Tweed.   We are not re-inventing the wheel here… no one should beat Tweed in mass pot sales.  Not in the first few years anyway.  The ones with the money will be the winners in the end because if they fail… they just buy their way out of trouble.

 Tweed.  Abattis.  Plandai.  All have major financial backing.



Enertopia Corp.  $0.60 


TOP:CNX; ENRT:OTC

Shares Out… 84.2M
Market Cap… $50.5M



Enertopia is another BC licenced producer which I value highly.

Clearly what is happening in Canadian medical marijuana is you are seeing former MMAR members come together and morph into MMPR licenced producers.  This is obviously the most ethical way of bringing together the two programs while the courts sort out the individual rights of the patient.   ENRT is a collaboration of MMAR growers including partially owned ‘The World of Marihuana Productions Ltd.’ and ‘The Green Canvas Ltd.’   The injunction affects these former MMAR growers the least and it actually allows for a smoother transition for these growers upgrading their facilities while allowing a legal avenue to sell their pot immediately.   Another ethical investing bonus is that many medical marijuana patients will have an easy time accepting the transition of MMAR grower/Compassion Club retail outlet to MMPR producer/distributor like Enertopia.

ENRT has put together a strong management team including bringing on Cannabis Science’s Dr. Melamede to the advisory board.  The company is a little weak on the finance side with a $2.75M private placement still open after almost a month.  On the bright side… the company has exercised several warrants bringing in a good chunk of change into the till over the last month.   So if you want a private placement and are late to the party… ENRT is a good second tier play behind Abattis and Tweed in Canada.

That being said… they overspent on Stuart Gray.  $5k a month for social media?

Are you kidding me?   Maybe I should start up my promotions company again.  At $5k he better be working the phones.   I wouldn’t pay more than $2,500 a month for my own social media service.  That is what I value an SEO at anyway.



Next Gen Metals $0.36



N:CNX; NXTTF:OTC

Shares Out… 22.4M
Market Cap… $8.1M
 


Next Gen Metals is a company I will give a shot.  Harry Barr is what I call a try hard.   He is somewhat honest although the money that backs him isn’t always and is typical VSE style money.  So ye be warned about Next Gen.  It doesn’t mean that Harry Barr won’t succeed.

Again… cannabis is an established industry and is low risk as long as you have the money and have a plan which Harry Barr and has both.

Next Gen is angling to be the marijuana venture capitalist on the West Coast.    If Jimmy had any semblance of family… this is what I would be doing right now; but we all do our own thing and he is the only one with the money in the family so without him nothing on a large scale gets done.

So I present to you…  Harry Barr, Vancouver cannabis entrepreneur/venture capitalist.

Coming back to reality… I really like the plan Harry has set forth at Next Gen so I am on board.   They have set up a conference series in Canada called the ‘Green Rush Conferences’.  There is a US conference that is similar that completely sells out all the time and is in extremely high demand.  It is not as investment oriented though so Green Rush as very good market niche with developing a format similar to Cambridge.   Once Trudeau legalizes cannabis in Canada, this conference will be in every major Canadian city for the next decade just like Cambridge was and still is.  Not only that, because Harry is a first mover, Green Rush will gain international popularity as an investment oriented cannabis conference.

What a great idea for a Venture Capitalist, eh?

Create the tradeshows and attract the top Cannabis talent across the country so you have your pick of the litter to invest in.  Next Gen is the Canadian version of Mentor Capital MNTR.  They have a slightly different approach with the tradeshow/VC model; but in the end, basically a great way to get broad exposure to the industry.   I expect really good things out of Next Gen as the industry makes its way towards outright legalization in the 2 to 3 years.




Affinor Resources $0.385

AFI:CNX

Shares Out… 35.4M
Market Cap…  $13.6M


Affinor Resources is the little engine that could.  I can’t help myself and have ignored every other Canadian story in the 5th spot except for AFI.  So what differentiates AFI from the mountain of other companies that have announced intentions to pursue the cannabis industry but have not announced anything concrete?

One thing.  Nick Brusatore.

Nick is a mad scientist hands down.  He is cowboy who is gung ho.  He is probably one of the best pot growers this side of the Rockies.   All of Abattis growing technology and growing operations were the responsibility of Nick.  ATTBF had the pick of the litter and they went with Nick and bought out his Vertical Growing technology for 6M shares.   The recent surge in pot stocks has made Nick an overnight marijuana millionaire.  With getting pushed out at Abattis, he has decided he wants his own little marijuana company and bought 10% of AFI on the open market.

That is what differentiates AFI from the rest.  Nick Brusatore. They got a freaking gung ho mad scientist overnight marijuana millionaire hanging on the bid of AFI.  Do I think he is done at 10%?  No.

If the folk at AFI can manage to keep a leash on Nick, AFI could become quite the sleeper pick.   Nick is what I refer to as ‘human capital’ and is my human capital pick of the bunch.  I am buying AFI simply based on Nick Brusatore.  He is a little wet behind the ears when it comes to investing and business, but that is what the folks at AFI are for… to guide him along in this area.

I would certainly get behind Nick Brusatore before I would ever get behind ‘Scott Walters’ or ‘Dean Laidlow’.  Who are these people?  I don’t know.  But I do know Nick, and I do know he is a great ‘talent’ to have on the team, even if he did muscle his way on board.



Christopher Skidmore